These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8241936)

  • 1. Percutaneous nephrostomy in malignant urinary tract obstruction.
    Bhandari M; Sinha S
    Natl Med J India; 1993; 6(5):218. PubMed ID: 8241936
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephrostomy. Relief of upper urinary tract in non-malignant and malignant diseases].
    Walter S
    Ugeskr Laeger; 2009 Mar; 171(11):871. PubMed ID: 19278607
    [No Abstract]   [Full Text] [Related]  

  • 4. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of percutaneous nephrostomy in malignant ureteric obstruction.
    Chapman ME; Reid JH
    Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous nephrostomy for ureteral obstruction caused by malignancy].
    Nägelein R
    Dtsch Med Wochenschr; 1997 Mar; 122(12):385. PubMed ID: 9118796
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous nephrostomy for malignant ureteral obstruction in children. Report of six cases.
    Montagne JP; Couanet D; Geoffray A; Neuenschwander S
    Ann Radiol (Paris); 1986; 29(3-4):401-5. PubMed ID: 3752880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relief of upper urinary tract].
    Mortensen J
    Ugeskr Laeger; 2009 Apr; 171(18):1539; author reply 1539. PubMed ID: 19425267
    [No Abstract]   [Full Text] [Related]  

  • 10. [Percutaneous nephrostomy in malignant ureteral obstruction].
    Demetriou D; Sebeikat D
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
    Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
    Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper urinary tract cancer--challenges for the urologist.
    Bostrom PJ; Soloway MS
    J Urol; 2007 Jul; 178(1):12-3. PubMed ID: 17574051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and methods of invasive minimal urinary derivations in oncology].
    Praz V; Chollet Y; Jichlinski P
    Rev Med Suisse; 2007 Dec; 3(136):2788-90, 2792. PubMed ID: 18183814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
    Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
    J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction.
    Alma E; Ercil H; Vuruskan E; Altunkol A; Unal U; Gurlen G; Goren V; Gurbuz ZG
    Support Care Cancer; 2020 Nov; 28(11):5581-5588. PubMed ID: 32757161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.